Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mRNA Vaccines against Flaviviruses
Clayton J. Wollner, Justin M. Richner
Vaccines (2021) Vol. 9, Iss. 2, pp. 148-148
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Namit Chaudhary, Drew Weissman, Kathryn A. Whitehead
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 11, pp. 817-838
Open Access | Times Cited: 984
Dengue: A Growing Problem With New Interventions
Joshua M. Wong, Laura E. Adams, Anna P. Durbin, et al.
PEDIATRICS (2022) Vol. 149, Iss. 6
Open Access | Times Cited: 78
Current Developments and Challenges of mRNA Vaccines
Jinjin Chen, Jianzhu Chen, Qiaobing Xu
Annual Review of Biomedical Engineering (2022) Vol. 24, Iss. 1, pp. 85-109
Open Access | Times Cited: 75
mRNA-based vaccines and therapeutics: an in-depth survey of current and upcoming clinical applications
Yu‐Shiuan Wang, Monika Kumari, Guanhong Chen, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 74
Recent Advancement in mRNA Vaccine Development and Applications
Nojoud AL Fayez, Majed S. Nassar, Abdullah A. Alshehri, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1972-1972
Open Access | Times Cited: 64
mRNA vaccines for infectious diseases — advances, challenges and opportunities
Norbert Pardi, Florian Krammer
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 16
Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future
Muhammad Bashir Bello, Ahlam Alsaadi, Asif Naeem, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access | Times Cited: 2
Current Advances in Zika Vaccine Development
Yuchen Wang, Ling Lin, Zilei Zhang, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1816-1816
Open Access | Times Cited: 62
A review on Zika vaccine development
Zhe‐Yu Peng, Yang Song, Hong‐Zheng Lu, et al.
Pathogens and Disease (2024) Vol. 82
Open Access | Times Cited: 9
Current status and perspectives on vaccine development against dengue virus infection
Jisang Park, Ju Kim, Yong‐Suk Jang
The Journal of Microbiology (2022) Vol. 60, Iss. 3, pp. 247-254
Open Access | Times Cited: 36
Vaccine development for mosquito-borne viral diseases
Zhiwei Huang, Yuxuan Zhang, Hongyu Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development
Moataz Dowaidar
Cellular Signalling (2024) Vol. 117, pp. 111116-111116
Closed Access | Times Cited: 8
Potential of cell-penetrating peptides (CPPs) in delivery of antiviral therapeutics and vaccines
Issa Sadeghian, Reza Heidari, Sara Sadeghian, et al.
European Journal of Pharmaceutical Sciences (2021) Vol. 169, pp. 106094-106094
Open Access | Times Cited: 38
Tick-Borne Encephalitis—Review of the Current Status
Małgorzata Kwaśnik, J. Rola, Wojciech Rożek
Journal of Clinical Medicine (2023) Vol. 12, Iss. 20, pp. 6603-6603
Open Access | Times Cited: 16
mRNA vaccine development and applications: A special focus on tumors (Review)
Bangjie Chen, Yipin Yang, Xinyi Wang, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Closed Access | Times Cited: 4
Engineering Modified mRNA-Based Vaccine against Dengue Virus Using Computational and Reverse Vaccinology Approaches
Mamuna Mukhtar, Amtul Wadood Wajeeha, Najam us Sahar Sadaf Zaidi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13911-13911
Open Access | Times Cited: 16
Virulence and Immune Evasion Strategies of FMDV: Implications for Vaccine Design
Gisselle N. Medina, F. Dı́az San Segundo
Vaccines (2024) Vol. 12, Iss. 9, pp. 1071-1071
Open Access | Times Cited: 3
Advances in mRNA and other vaccines against MERS-CoV
Wanbo Tai, Xiujuan Zhang, Yang Yang, et al.
Translational research (2021) Vol. 242, pp. 20-37
Open Access | Times Cited: 23
Novel approaches for the rapid development of rationally designed arbovirus vaccines
Joyce W. M. van Bree, Imke Visser, Jo M. Duyvestyn, et al.
One Health (2023) Vol. 16, pp. 100565-100565
Open Access | Times Cited: 8
A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice
Lihong He, Wenqiang Sun, Limin Yang, et al.
Virologica Sinica (2022) Vol. 37, Iss. 5, pp. 746-757
Open Access | Times Cited: 14
Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
Wubetu Yihunie, Getinet Nibret, Yibeltal Aschale
Clinical Pharmacology Advances and Applications (2023) Vol. Volume 15, pp. 77-98
Open Access | Times Cited: 7
mRNA Innovates the Vaccine Field
Norbert Pardi
Vaccines (2021) Vol. 9, Iss. 5, pp. 486-486
Open Access | Times Cited: 14
Interactions of host miRNAs in the flavivirus 3´UTR genome: From bioinformatics predictions to practical approaches
Rodolfo Gamaliel Avila‐Bonilla, Juan Santiago Salas-Benito
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 8
RNA therapeutics for infectious diseases
Le Minh Tu Phan, Thi Thuy Duong Pham, Van Thai Than
Progress in molecular biology and translational science (2024), pp. 109-132
Closed Access | Times Cited: 1
Current development of Zika virus vaccines with special emphasis on virus-like particle technology
Velasco Cimica, Jose M. Galarza, Sujatha Rashid, et al.
Expert Review of Vaccines (2021) Vol. 20, Iss. 11, pp. 1483-1498
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top